WELLINGTON MANAGEMENT GROUP LLP - 30 Jun 2025 SCHEDULE 13G/A Report for Celldex Therapeutics, Inc. Common Stock (CLDX)

Filing Manager
WELLINGTON MANAGEMENT GROUP LLP
Reporting Manager
Wellington Management Group LLP
Security
Celldex Therapeutics, Inc. Common Stock
Symbol
CLDX
Shares outstanding
66,231,975 shares
Disclosed Ownership
5,232,326 shares
Ownership
7.9%
Form type
SCHEDULE 13G/A
Filing time
12 Aug 2025, 10:34:26 UTC
Date of event
30 Jun 2025
Previous filing
12 May 2025
Next filing
07 Nov 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Wellington Management Group LLP 7.9% 5,232,326 0 4,862,458 Taisia Lowe Regulatory Analyst
Wellington Group Holdings LLP 7.9% 5,232,326 0 4,862,458 Taisia Lowe Regulatory Analyst
Wellington Investment Advisors Holdings LLP 7.9% 5,232,326 0 4,862,458 Taisia Lowe Regulatory Analyst
Wellington Management Company LLP 7.7% 5,232,326 0 4,856,094 Taisia Lowe Regulatory Analyst